Evidence map›Paper›PMID 39171986›Full record

ArticleBriefings in bioinformatics2024

GR-pKa: a message-passing neural network with retention mechanism for pKa prediction.

Runyu Miao, Danlin Liu, Liyun Mao, Xingyu Chen, Leihao Zhang, Zhen Yuan, Shanshan Shi, Honglin Li, Shiliang Li

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Unifying pJournal of chemical information and modeling · 2026
    Article
  2. Review
  3. Journal of pharmaceutical analysis · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Runyu MiaoShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, No. 130, Meilong Road, Xuhui District, Shanghai, 200237, China.
Danlin LiuInnovation Center for AI and Drug Discovery, School of Pharmacy, East China Normal University, No. 3663, Zhongshan North Road, Putuo District, Shanghai, 200062, China.
Liyun MaoShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, No. 130, Meilong Road, Xuhui District, Shanghai, 200237, China.
Xingyu ChenShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, No. 130, Meilong Road, Xuhui District, Shanghai, 200237, China.
Leihao ZhangShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, No. 130, Meilong Road, Xuhui District, Shanghai, 200237, China.
Zhen YuanShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, No. 130, Meilong Road, Xuhui District, Shanghai, 200237, China.
Shanshan ShiShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, No. 130, Meilong Road, Xuhui District, Shanghai, 200237, China.
Honglin LiShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, No. 130, Meilong Road, Xuhui District, Shanghai, 200237, China.
Shiliang LiShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, No. 130, Meilong Road, Xuhui District, Shanghai, 200237, China.ORCID 0000-0003-4414-237X

Funding

National Natural Science Foundation of China 82150208
6 · The paper itself

Abstract

During the drug discovery and design process, the acid-base dissociation constant (pKa) of a molecule is critically emphasized due to its crucial role in influencing the ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties and biological activity. However, the experimental determination of pKa values is often laborious and complex. Moreover, existing prediction methods exhibit limitations in both the quantity and quality of the training data, as well as in their capacity to handle the complex structural and physicochemical properties of compounds, consequently impeding accuracy and generalization. Therefore, developing a method that can quickly and accurately predict molecular pKa values will to some extent help the structural modification of molecules, and thus assist the development process of new drugs. In this study, we developed a cutting-edge pKa prediction model named GR-pKa (Graph Retention pKa), leveraging a message-passing neural network and employing a multi-fidelity learning strategy to accurately predict molecular pKa values. The GR-pKa model incorporates five quantum mechanical properties related to molecular thermodynamics and dynamics as key features to characterize molecules. Notably, we originally introduced the novel retention mechanism into the message-passing phase, which significantly improves the model's ability to capture and update molecular information. Our GR-pKa model outperforms several state-of-the-art models in predicting macro-pKa values, achieving impressive results with a low mean absolute error of 0.490 and root mean square error of 0.588, and a high R2 of 0.937 on the SAMPL7 dataset.

Indexed as

Neural Networks, ComputerDrug DiscoveryThermodynamicsdeep learningmulti-fidelity learningpKa predictionretention mechanism

Identifiers

PMID39171986
PMCPMC11339865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.